Provider Prices in the Commercial Sector: Reaching a Common Understanding / Hospital Prices

Why It Matters

Hospital pricing dominates U.S. health‑care costs; improving data transparency and antitrust oversight could significantly lower spending for employers and patients alike.

Key Takeaways

• Hospital care consumes 31% of U.S. health spending, outpacing drugs.
• Private insurance costs rose nearly 9% in 2024, driving overall growth.
• Legislation aims to give employers full claims data for price negotiation.
• Price transparency tools remain underused due to complexity and insurance layers.
• Antitrust enforcement and price caps are proposed to curb hospital price inflation.

Summary

The video opens with Max Seltzer, health‑policy director for Sen. Roger Marshall, highlighting that hospital services represent the single largest share of national health expenditures—about 31%—far exceeding the 9% share of prescription drugs. He notes that private insurance premiums jumped almost 9% in 2024, contributing to the overall 7.2% rise in health spending, and stresses that policymakers often focus on drug pricing while overlooking hospital costs.

Seltzer outlines two legislative priorities: empowering consumers with transparent price information for elective procedures, and mandating that self‑funded employers obtain comprehensive claims data under HIPAA. With richer data, employers could identify pricing differentials, redesign networks, and negotiate more aggressively with providers. He argues that targeting hospital payment reforms would yield the greatest impact on affordability.

Panelists later discuss the semantics of “price” versus “quantity,” noting that high price levels do not always correlate with rapid price growth. They debate whether excess medical inflation is near zero once adjusted for overall inflation, and explore drivers such as fee‑schedule shifts, new service codes, and site‑of‑care changes. Antitrust enforcement, transparency tools, and price caps emerge as potential policy levers, though transparency’s effectiveness is questioned due to data complexity and insurance cushioning.

The discussion underscores that addressing hospital pricing—through data access, antitrust scrutiny, and possible caps—could curb the dominant cost driver in U.S. health care. For employers and policymakers, better visibility into provider charges promises more strategic network design and cost containment, while consumers may eventually benefit from clearer price signals for elective care.

Original Description

On April 30, Health Affairs Publishing hosted a symposium exploring how provider prices affect commercial health care spending, what drives price variation and growth, and how policymakers and stakeholders can interpret the evidence.

The first panel of this symposium focused on how provider prices contribute to overall commercial health spending growing with a focus on hospitals.

Panelists included Max Seltzer, Melinda Bunton, Michael Chernew, and Irene Papanicolas.

---

Visit Health Affairs: http://www.healthaffairs.org

Subscribe and Listen to our Podcasts: https://www.healthaffairs.org/podcasts

Sign up for our free Newsletters: https://www.healthaffairs.org/newsletters